LC3β | Beclin-1 | |||
---|---|---|---|---|
Low (%) | High (%) | Low (%) | High (%) | |
No. patients (%) | 54 (53.5) | 47 (46.5) | 69 (68.3) | 32 (31.7) |
Clinical T stage | ||||
cT2-3 | 53 (98.1) | 45 (95.7) | 69 (100) | 29 (90.6) |
cT4 | 1 (1.9) | 2 (4.3) | 0 (0) | 3 (9.4) |
P value | 0.596 | 0.030 | ||
Clinical N stage | ||||
cN0 | 26 (48.1) | 26 (55.3) | 34 (49.3) | 18 (56.3) |
cN1-2 | 28 (51.9) | 21 (44.7) | 35 (50.7) | 14 (43.7) |
P value | 0.603 | 0.661 | ||
Grade | ||||
Well/moderately | 49 (90.7) | 42 (95.5) | 62 (89.9) | 32 (100) |
Poorly | 5 (9.3) | 2 (4.5) | 7 (10.1) | 0 (0) |
P value | 0.444 | 0.094 | ||
ypCR | ||||
Yes | 19 (35.2) | 4 (8.5) | 17 (24.6) | 6 (18.8) |
No | 35 (64.8) | 43 (91.5) | 52 (75.4) | 26 (81.2) |
P value | 0.003 | 0.688 |